vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and GRANITE CONSTRUCTION INC (GVA). Click either name above to swap in a different company.

GRANITE CONSTRUCTION INC is the larger business by last-quarter revenue ($912.5M vs $749.2M, roughly 1.2× CLOVER HEALTH INVESTMENTS, CORP.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — 3.6% vs -4.0%, a 7.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 30.4%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs -8.2%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Granite Construction Inc. is a civil construction company and aggregate producer, a member of the S&P 600 Index based and founded in Watsonville, California, and is the parent corporation of Granite Construction Company. The company is both a heavy civil construction contractor and construction aggregate manufacturer, owning or leasing quarries in several Western states for extracting mostly sands, gravel, and crushed stone products. The company was under investigation from the SEC from 2019 ...

CLOV vs GVA — Head-to-Head

Bigger by revenue
GVA
GVA
1.2× larger
GVA
$912.5M
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+31.6% gap
CLOV
62.0%
30.4%
GVA
Higher net margin
CLOV
CLOV
7.6% more per $
CLOV
3.6%
-4.0%
GVA
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
-8.2%
GVA

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLOV
CLOV
GVA
GVA
Revenue
$749.2M
$912.5M
Net Profit
$27.3M
$-36.4M
Gross Margin
11.2%
Operating Margin
3.6%
Net Margin
3.6%
-4.0%
Revenue YoY
62.0%
30.4%
Net Profit YoY
-23.9%
EPS (diluted)
$0.05
$-0.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
GVA
GVA
Q1 26
$749.2M
$912.5M
Q4 25
$487.7M
$1.2B
Q3 25
$496.6M
$1.4B
Q2 25
$477.6M
$1.1B
Q1 25
$462.3M
$699.5M
Q4 24
$337.0M
$977.3M
Q3 24
$331.0M
$1.3B
Q2 24
$356.3M
$1.1B
Net Profit
CLOV
CLOV
GVA
GVA
Q1 26
$27.3M
$-36.4M
Q4 25
$-49.3M
$52.0M
Q3 25
$-24.4M
$102.9M
Q2 25
$-10.6M
$71.7M
Q1 25
$-1.3M
$-33.7M
Q4 24
$-22.1M
$41.5M
Q3 24
$-9.2M
$79.0M
Q2 24
$7.4M
$36.9M
Gross Margin
CLOV
CLOV
GVA
GVA
Q1 26
11.2%
Q4 25
14.4%
Q3 25
18.2%
Q2 25
17.7%
Q1 25
12.0%
Q4 24
15.4%
Q3 24
24.5%
15.9%
Q2 24
30.3%
15.2%
Operating Margin
CLOV
CLOV
GVA
GVA
Q1 26
3.6%
Q4 25
-10.1%
6.4%
Q3 25
-4.9%
10.0%
Q2 25
-2.2%
9.2%
Q1 25
-0.3%
-5.7%
Q4 24
-6.4%
6.2%
Q3 24
-2.7%
8.2%
Q2 24
2.0%
7.9%
Net Margin
CLOV
CLOV
GVA
GVA
Q1 26
3.6%
-4.0%
Q4 25
-10.1%
4.5%
Q3 25
-4.9%
7.2%
Q2 25
-2.2%
6.4%
Q1 25
-0.3%
-4.8%
Q4 24
-6.6%
4.2%
Q3 24
-2.8%
6.2%
Q2 24
2.1%
3.4%
EPS (diluted)
CLOV
CLOV
GVA
GVA
Q1 26
$0.05
$-0.96
Q4 25
$1.23
Q3 25
$1.98
Q2 25
$1.42
Q1 25
$-0.77
Q4 24
$0.99
Q3 24
$1.57
Q2 24
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
GVA
GVA
Cash + ST InvestmentsLiquidity on hand
$177.6M
$265.7M
Total DebtLower is stronger
$1.2B
Stockholders' EquityBook value
$339.4M
$1.1B
Total Assets
$697.7M
$3.8B
Debt / EquityLower = less leverage
1.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
GVA
GVA
Q1 26
$177.6M
$265.7M
Q4 25
$78.3M
$600.2M
Q3 25
$547.2M
Q2 25
$385.3M
Q1 25
$422.8M
Q4 24
$194.5M
$585.6M
Q3 24
$288.0M
$472.4M
Q2 24
$254.8M
$377.2M
Total Debt
CLOV
CLOV
GVA
GVA
Q1 26
$1.2B
Q4 25
$1.3B
Q3 25
$1.3B
Q2 25
$740.4M
Q1 25
$739.7M
Q4 24
$739.0M
Q3 24
$738.6M
Q2 24
$738.9M
Stockholders' Equity
CLOV
CLOV
GVA
GVA
Q1 26
$339.4M
$1.1B
Q4 25
$308.7M
$1.2B
Q3 25
$340.9M
$1.2B
Q2 25
$344.2M
$1.1B
Q1 25
$336.1M
$993.5M
Q4 24
$341.1M
$1.0B
Q3 24
$342.2M
$1.0B
Q2 24
$324.9M
$931.7M
Total Assets
CLOV
CLOV
GVA
GVA
Q1 26
$697.7M
$3.8B
Q4 25
$541.0M
$4.0B
Q3 25
$559.7M
$4.1B
Q2 25
$575.0M
$3.1B
Q1 25
$583.7M
$2.9B
Q4 24
$580.7M
$3.0B
Q3 24
$653.0M
$3.1B
Q2 24
$674.2M
$2.9B
Debt / Equity
CLOV
CLOV
GVA
GVA
Q1 26
1.15×
Q4 25
1.14×
Q3 25
1.16×
Q2 25
0.70×
Q1 25
0.74×
Q4 24
0.73×
Q3 24
0.73×
Q2 24
0.79×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons